Interleukin-11 promotes the progress of gastric carcinoma via abnormally expressed versican

International Journal of Biological Sciences

Volumn 8, Issue 3, 2012, Pages 383-393

  Zhang, Zhenwei ^a   Zhang, Jianpeng ^a   Miao, Lei ^b   Liu, Ke ^c   Yang, Shengsheng ^a   Pan, Chuanyong ^a   Jiao, Binghua ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gastric carcinoma; IL 11; Migration; Versican

Indexed keywords

IL11 PROTEIN, HUMAN; INTERLEUKIN 11; ISOPROTEIN; MESSENGER RNA; RECOMBINANT PROTEIN; RNA; SMALL INTERFERING RNA; TUMOR PROTEIN; VCAN PROTEIN, HUMAN; VERSICAN;

ADENOCARCINOMA; AGED; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; CELL MOTION; CHEMISTRY; CYTOLOGY; DISEASE COURSE; DRUG ANTAGONISM; DRUG EFFECT; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STOMACH; STOMACH TUMOR; TUMOR CELL LINE;

ADENOCARCINOMA; AGED; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-11; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTEIN ISOFORMS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; STOMACH; STOMACH NEOPLASMS; VERSICANS;

EID: 84863229673     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.3579     Document Type: Article

References (48)

1. Oue N, Sentani K, Sakamoto N, et al. Characteristic gene expression in stromal cells of gastric cancers among atomic-bomb survivors. Int J Cancer. 2009; 124: 1112-21.
2. Hartgrink HH, Jansen EP, van Grieken NC, et al. Gastric cancer. Lancet. 2009; 374: 477-90.
3. Ricciardelli C and Rodgers RJ: Extracellular matrix of ovarian tumors. Semin Reprod Med 2006; 24: 270-82.
4. Ricciardelli C, Sakko AJ, Ween MP, et al. The biological role and regulation of versican levels in cancer. Cancer Metastasis Rev. 2009; 28: 233-45.
5. Wight TN. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol. 2002; 14: 617-23.
6. Zako M, Shinomura T, Ujita M, et al. Expression of PG-M (V3), an alternatively spliced form of PG-M without a chondroitin sulfate attachment in region in mouse and human tissues. J Biol Chem. 1995; 270: 3914-8.
7. Landolt RM, Vaughan L, Winterhalter KH, et al. Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development 1995; 121: 2303-12.
8. Schmalfeldt M, Dours-Zimmermann MT, Winterhalter KH. Versican V2 is a major extracellular matrix component of the mature bovine brain. J Biol Chem. 1998; 273: 15758-64.
9. Wu YJ, La Pierre DP, Wu J, et al. The interaction of versican with its binding partners. Cell Res. 2005; 15: 483-94.
10. LeBaron RG, Zimmermann DR, Ruoslahti E. Hyaluronate binding properties of versican. J Biol Chem. 1992; 267:10003-10.
11. Aspberg A, Binkert C, Ruoslahti E. The versican C-type lectin domain recognizes the adhesion protein tenascin-R. Proc Natl Acad Sci U S A. 1995; 92: 10590-4.
12. Aspberg A, Adam S, Kostka G, et al. Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. J Biol Chem. 1999; 274: 20444-9.
13. Isogai Z, Aspberg A, Keene DR, et al. Versican interacts with fibrillin-1 and links extracellular microfibrils to other connective tissue networks. J Biol Chem. 2002; 277: 4565-72.
14. Yamagata M, Yamada KM, Yoneda M, et al. Chondroitin sulfate proteoglycan (PG-M-like proteoglycan) is involved in the binding of hyaluronic acid to cellular fibronectin. J Biol Chem. 1986;261:13526-35.
15. Kawashima H, Hirose M, Hirose J, et al. Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican,to L-selectin, P-selectin, and CD44. J Biol Chem. 2000; 275: 35448-56.
16. Wu Y, Chen L, Zheng PS, et al. beta 1-Integrin-mediated glioma cell adhesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PG-M/versican. J Biol Chem. 2002; 277: 12294-301.
17. Evanko SP, Angello JC, Wight TN. Formation of hyaluronan and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999; 19: 1004-13.
18. Choocheep K, Hatano S, Takagi H, et al. Versican facilitates chondrocyte differentiation and regulates joint morphogenesis. J Biol Chem. 2010; 285: 21114-25.
19. Yang BL, Zhang Y, Cao L, et al. Cell adhesion and proliferation mediated through the G1 domain of versican. J Cell Biochem. 1999; 72: 210-20.
20. Setoguchi T, Kikuchi H, Yamamoto M, et al. Microarray analysis identifies versican and CD9 as potent prognostic markers in gastric gastrointestinal stromal tumors. Cancer Sci. 2011; 102: 883-9.
21. Theocharis AD, Vynios DH, Papageorgakopoulou N, et al. Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma. Int J Biochem Cell Biol. 2003; 35: 376-90.
22. Ju H, Lim B, Kim M, et al. Genetic variants A1826H and D2937Y in GAG-beta domain of versican influence susceptibility to intestinal-type gastric cancer. J Cancer Res Clin Oncol. 2010; 136: 195-201.
23. Berdiaki A, Zafiropoulos A, Fthenou E, et al. Regulation of hyaluronan and versican deposition by growth factors in fibrosarcoma cell lines. Biochimica Biophysica Acta. 2008; 1780: 194-202.
24. Norian JM, Malik M, Parker CY, et al. Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas. Reprod Sci. 2009; 16:1153-64.
25. Lemire JM, Chan CK, Bressler S, et al. Interleukin-1beta selectively decreases the synthesis of versican by arterial smooth muscle cells. J Cell Biochem. 2007; 101: 753-66.
26. Du X, Williams DA. Interleukin-11: review of molecular, cell biology, and clinical use. Blood. 1997; 89: 3897-908.
27. Nakayama T, Yoshizaki A, Izumida S, et al. Expression of in terluekin-11 (IL-11) and IL-11 receptor alpha in human gastric carcinoma and IL-11 upregulates the invasive activity of human gastric carcinoma cells. Int J Oncol. 2007; 30: 825-33.
28. Reddy KB, Nabha SM, Atanaskova N. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev. 2003; 22: 395-403.
29. Jackson CB, Judd LM, Menheniott TR, et al. Augmented gp130-mediated cytokine signaling accompanies human gastric cancer progression. J Pathol. 2007; 213: 140-51.
30. Huang C, Rajfur Z, Yousefi N, et al. Talin phosphorylation by Cdk5 regulates Smurf1-mediated talin head ubiquitylation and cell migration. Nat Cell Biol. 2009; 11: 624-30.
31. Zhang K, Yao HP, Wang MH. Activation of RON differentially regulates claudin expression and localization: role of claudin-1 in RON-mediated epithelial cell motility. Carcinogenesis. 2008; 29: 552-9.
32. Ernst M, Najdovska M, Grail D, et al. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest. 2008;118:1727-38.
33. Kim S, Takahashi H, Lin WW, et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature. 2009; 457: 102-6.
34. Wu YJ, Wu J, Lee DY, et al. Versican protects cells from oxidative stress-induced apoptosis. Matrix Biology 2005; 24: 3-13.
35. Hernández D, Miquel-Serra L, Docampo MJ, et al. Role of versican V0/V1 and CD44 in the regulation of human melanoma cell behavior. Int J Mol Med. 2011; 27: 269-75.
36. Grivennikov SI, Greten FR, Karin M. Immunity, Inflammation, and Cancer. Cell 2010; 140: 883-99.
37. Kischel P, Waltregny D, Dumont B, et al. Versican overexpression in human breast cancer lesions: known and new isoforms for stromal tumor targeting. Int J Cancer. 2010, 126: 640-50.
38. True LD, Hawley S, Norwood TH, et al. The accumulation of versican in the nodules of benign prostatic hyperplasia. Prostate. 2009; 69: 149-58.
39. Lemire JM, Merrilees MJ, Braun KR, et al. Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro. J Cell Physiol. 2002; 190: 38-45.
40. Miquel-Serra L, Serra M, Hernandez D, et al. V3 versican isoform expression has a dual role in human melanoma tumor growth and metastasis. Lab Invest. 2006; 86: 889-901.
41. Domenzain C, Docampo MJ, Serra M, et al. Differential expression of versican isoforms is a component of the human melanoma cell differentiation process. Biochim Biophys Acta. 2003; 1642: 107-14.
42. Syrokou A, Dobra K., Tzanakakis GN, et al. Synthesis and expression of mRNA encoding for different versican splice variants is related to the aggregation of human epithelial mesothelioma cells. Anticancer Res. 2002; 22:4157-62.
43. Wen CY, Ito M, Wang H, et al. IL-11 up-regulates Tie-2 expression during the healing of gastric ulcers in rats. World J Gastroenterol. 2003; 9: 788-90.
44. Wen CY, Ito M, Matsuu M, et al. Mechanism of the antiulcerogenic effect of IL-11 on acetic acid-induced gastric ulcer in rats. Life Sci. 2002; 70: 2997-3005.
45. Merchant JL. What lurks beneath: IL-11, via Stat3, promotes inflammation-associated gastric tumorigenesis. J Clin Invest. 2008; 118: 1628-31.
46. Howlett M, Judd LM, Jenkins B, et al. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130. Gastroenterology. 2005; 129: 1005-18.
47. Perides G, Asher RA, Lark MW, et al. Glial hyaluronate-binding protein: a product of metalloproteinase digestion of versican? Biochem J. 1995; 312 (Pt 2): 377-84.
48. Passi A, Negrini D, Albertini R, et al. The sensitivity of versican from rabbit lung to gelatinase A (MMP-2) and B (MMP-9) and its involvement in the development of hydraulic lung edema. FEBS Lett. 1999; 456: 93-6.